Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Change in Accured Expenses (2016 - 2020)

Historic Change in Accured Expenses for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$143000.0.

  • Glucotrack's Change in Accured Expenses rose 1551.86% to -$143000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$236000.0, marking a year-over-year increase of 1890.03%. This contributed to the annual value of $332000.0 for FY2023, which is 14057.97% up from last year.
  • Latest data reveals that Glucotrack reported Change in Accured Expenses of -$143000.0 as of Q4 2020, which was up 1551.86% from $55000.0 recorded in Q3 2020.
  • Glucotrack's 5-year Change in Accured Expenses high stood at $937276.0 for Q1 2017, and its period low was -$766248.0 during Q2 2017.
  • Moreover, its 5-year median value for Change in Accured Expenses was $29536.0 (2018), whereas its average is $34653.1.
  • Data for Glucotrack's Change in Accured Expenses shows a peak YoY increase of 32819.34% (in 2016) and a maximum YoY decrease of 265373.11% (in 2016) over the last 5 years.
  • Over the past 5 years, Glucotrack's Change in Accured Expenses (Quarter) stood at $133830.0 in 2016, then surged by 99.94% to $267582.0 in 2017, then tumbled by 74.5% to $68237.0 in 2018, then crashed by 348.06% to -$169268.0 in 2019, then increased by 15.52% to -$143000.0 in 2020.
  • Its Change in Accured Expenses was -$143000.0 in Q4 2020, compared to $55000.0 in Q3 2020 and -$99000.0 in Q2 2020.